Lucia Morbidelli Selected Research

zofenoprilate

10/2013

The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Morbidelli Research Topics

Disease

33	Neoplasms (Cancer) 07/2022 - 05/2002
5	Hypoxia (Hypoxemia) 01/2021 - 03/2018
4	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2016
3	Melanoma (Melanoma, Malignant) 07/2022 - 07/2016
3	Inflammation (Inflammations) 06/2021 - 01/2018
3	Ischemia 03/2021 - 01/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 03/2010
3	Atherosclerosis 03/2021 - 11/2004
2	Infections 03/2021 - 05/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2019
2	Edema (Dropsy) 01/2018 - 01/2003
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2015 - 11/2004
1	Hypertension (High Blood Pressure) 03/2021
1	Vascular Diseases (Vascular Disease) 03/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Mononeuropathies (Mononeuritis Multiplex) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Pain (Aches) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Carcinoma (Carcinomatosis) 03/2018
1	Retinal Diseases 01/2018
1	Retinal Neovascularization 01/2018
1	Multiple Sclerosis 01/2017
1	Carcinogenesis 01/2017
1	Polyps 01/2017
1	Heart Failure 03/2016
1	Vision Disorders (Hemeralopia) 07/2015

Drug/Important Bio-Agent (IBA)

12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2002
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2021 - 01/2004
5	EnzymesIBA 07/2022 - 11/2003
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018 - 12/2004
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2008
3	AntioxidantsIBA 06/2021 - 03/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
3	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 01/2003
3	PhytochemicalsIBA 01/2016 - 11/2004
2	AldehydesIBA 07/2022 - 12/2019
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2019 - 08/2007
2	Prostaglandins EIBA 01/2019 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 08/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 12/2018
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 03/2018 - 01/2004
2	CytokinesIBA 01/2018 - 02/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2016 - 03/2010
2	Nitric Oxide DonorsIBA 03/2016 - 01/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 01/2009
2	SuspensionsIBA 01/2015 - 01/2009
2	Peptides (Polypeptides)IBA 12/2004 - 11/2003
1	Neutralizing AntibodiesIBA 07/2022
1	erucinIBA 06/2021
1	GasotransmittersIBA 03/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 03/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Carbonic AcidIBA 04/2020
1	SulfonamidesIBA 04/2020
1	Carbonic Anhydrase IXIBA 04/2020
1	Olive OilIBA 03/2020
1	Sulfates (Sulfates, Inorganic)IBA 03/2020
1	PolyphenolsIBA 03/2020
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 03/2020
1	SLC-0111IBA 01/2020
1	IsoenzymesIBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 12/2019
1	Mitogen-Activated Protein KinasesIBA 08/2019
1	Sorafenib (BAY 43-9006)FDA Link 08/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2019
1	Poloxamer (Poloxamer 407)IBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	Aldehyde DehydrogenaseIBA 12/2018
1	CopperIBA 07/2018
1	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 03/2018
1	MetalsIBA 03/2018
1	matrigelIBA 03/2018
1	KallidinIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	BradykininIBA 01/2018
1	HydrolasesIBA 01/2017
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017
1	URB602IBA 01/2017
1	AzoxymethaneIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	Monoacylglycerol LipasesIBA 01/2017
1	Cyclin D1IBA 01/2017
1	Endothelin-1 (Endothelin 1)IBA 01/2017
1	Cyclic PeptidesIBA 07/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2016
1	Protective AgentsIBA 03/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2016
1	InterleukinsIBA 12/2014

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2003
2	Laser Therapy (Surgery, Laser) 03/2021 - 01/2019
2	Plant-Based Diet 05/2012 - 11/2004
1	Low-Level Light Therapy (LLLT) 01/2019
1	Lasers (Laser) 01/2019
1	Chemoprevention 01/2017
1	Drug Therapy (Chemotherapy) 03/2016
1	Anesthesia 01/2015